用mRNA加载的树突细胞癌疫苗的生产
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
在PubMed上查看摘要
概括
此摘要是机器生成的。这项研究详细介绍了一种产生带mRNA的树突细胞 (DC) 的方法. 这些工程化DCs的目的是作为治疗疫苗来增强抗瘤免疫力.
科学领域
- 免疫学
- 癌症研究
- 疫苗开发
背景情况
- 树突细胞 (DCs) 是强大的抗原呈现细胞 (APCs),对于启动抗瘤免疫反应至关重要.
- 作为有效向瘤细胞的治疗疫苗,正在探索DC.
- 包括mRNA在内的各种抗原配方正在研究以DC为基础的疫苗.
研究的目的
- 描述一种ex vivo生成树突细胞的协议.
- 详细介绍这些树突细胞与mRNA编码瘤抗原的过程.
- 根据良好制造实践 (GMP) 概述一种树突细胞疫苗的生产方法.
主要方法
- 周围血液单核细胞 (PBMC) 的分离.
- PBMCs的分化和成熟成树突细胞 (DCs).
- 用体外转录的mRNA编码特定瘤抗原或新抗原加载DC.
- 在整个过程中遵守良好制造实践 (GMP).
主要成果
- 成功生成功能性树突细胞.
- 用mRNA有效地加载树突细胞.
- 一个生产临床级 dendritic 细胞疫苗的标准化协议.
结论
- 描述的协议提供了一种可复制的方法来生成载有mRNA的树突细胞疫苗.
- 这种方法有望通过治疗性疫苗增强抗瘤免疫力.
- 坚持良好的生产方法可确保树突细胞疫苗在临床应用中的安全性和有效性.
相关概念视频
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.